Retatrutide is a GLP-1 drug, in the same family as Ozempic (semaglutide) and Mounjaro (tirzepatide)
Wegovy is FDA-approved and tested
A comprehensive program of nutritional and lifestyle counseling is critical to maximize overall efficacy and improve cost-effectiveness of GLP-1s for obesity Long-term Success of GLP-1s Hinges on More Than Just a Prescription A comprehensive program of nutritional and lifestyle counseling is critical to maximize overall efficacy and improve cost-effectiveness of GLP-1s for obesity GLP-1 (glucagon-like peptide-1) therapies can be powerful tools in managing obesity, with patients taking these medications seeing weight reductions of 518% in clinical trials, along with increased metabolism and benefits to their overall heart health
For the general population, this is manageable
Noom Noom scores 9.6/10 and takes our second spot for 2026
Peter Flatt, Ulster University, United Kingdom Updates Copyright 2021 Li, Gao, Guo, Wang, Hua, Gao, Shang, Lu and Xu